Aptar CSP Technologies, an active packaging solutions provider, has expanded capacity for producing multiple configurations of its 3-Phase Activ-Polymer technology to support increased demand for diagnostic test kits protection solutions.
 
The recent surge in the development of new COVID-19 test kits in tandem with pandemic-related supply chain challenges has led to increased demand for solutions to improve result accuracy of critical diagnostic tests. Aptar’s 3-Phase Activ-Polymer technology provides customizable integrated solutions that create a microclimate within both strip-based and cassette-format lateral flow tests. The integration of this technology adsorbs moisture to provide environmental conditions that preserve test integrity and ensure accurate results.
 
“With the coronavirus pandemic intensifying, not only are we dealing with a situation where test accuracy is of the utmost importance, but speed of execution is critical and protection throughout the supply chain has become a more formidable challenge,” said Badre Hammond, VP, Commercial Operations, Aptar CSP Technologies. “As a global leader in the protection of diagnostic test kits and trusted partner of leading diagnostic manufacturers for more than 20 years, Aptar has a depth of expertise in this market that can be readily applied to quickly solve the stability challenges diagnostic kit manufacturers are facing as they bring these important test kits to market.”